Overview

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Status:
Terminated

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

Subjects will be randomly assigned to one of 3 treatment groups and receive 325 mg (65 mg elemental iron) iron supplements twice daily.

Phase:

Phase 3

Details

Lead Sponsor:

Repros Therapeutics Inc.